On Feb. 11, 2021, Moderna announced that the Qatar Ministry of Public Health had issued an emergency use authorization for COVID-19 Vaccine Moderna.

The approval was based on the totality of scientific evidence shared by the Company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30. Qatar secured access to COVID-19 Vaccine Moderna through a supply agreement announced on October 26, 2020.

Moderna also received authorization for its COVID-19 vaccine from health agencies in the United States, Canada, Israel, the European Union, the United Kingdom, Switzerland and Singapore. Moderna is also working with additional health agencies and with the World Health Organization on the authorization of its vaccine in respective jurisdictions.